International Journal of Medical and All Body Health Research  |  e-ISSN: 2582-8940  |  Double-Blind Peer Review  |  Open Access  |  CC BY-NC-SA 4.0

Current Issues
     2026:7/4

International Journal of Medical and All Body Health Research

e-ISSN: 2582-8940 | Open Access

Probiotic Use in Gastrointestinal (G.I.T.) Infections

Authors

  • Dr. Pradyuman Kaushik
  • Dr. J Srinivas
  • Dr. Rati Saxena
  • Dr. Prashant Jr

Article Information

Volume / Issue7 / 3 (July-August 2026)
Pages61-65
AccessOpen Access

Publication Timeline

  • Published

Full Text (PDF)

Open Access - Free to Download

Download Full Article (PDF) JATS XML

Abstract

Probiotics — live microorganisms that, when administered in adequate amounts, confer a health benefit on the host — have been widely investigated as adjunctive or stand-alone therapy for gastrointestinal (GIT) infections. This narrative review synthesises evidence from systematic reviews, meta-analyses, large randomised controlled trials, and clinical guidelines on probiotic use in acute infectious diarrhoea, antibiotic-associated diarrhoea (AAD), Clostridioides difficile-associated diarrhoea (CDAD), Helicobacter pylori infection, and traveller's diarrhoea. Relevant literature was identified through PubMed, the Cochrane Library, and Google Scholar. Pooled evidence indicates that selected strains — particularly Lactobacillus rhamnosus GG and Saccharomyces boulardii — can reduce the duration and severity of acute diarrhoea and lower the incidence of AAD and CDAD, while multi-strain formulations modestly improve H. pylori eradication rates and reduce therapy-related adverse effects. However, an updated 2020 Cochrane review and two large paediatric emergency-department trials have tempered earlier optimism, underscoring strain specificity, dosing, timing, and publication bias as major sources of heterogeneity. Probiotic supplementation appears safe in immunocompetent populations and offers measurable, though strain- and indication-dependent, benefit, supporting cautious, evidence-guided clinical use.

How to Cite

Kaushik, P., Srinivas, J., Saxena, R., & Jr, P. (2026). Probiotic Use in Gastrointestinal (G.I.T.) Infections. International Journal of Medical and All Body Health Research, 7(3), 61-65. https://doi.org/10.54660/IJMBHR.2026.7.3.61-65

Kaushik, Pradyuman, et al. "Probiotic Use in Gastrointestinal (G.I.T.) Infections." International Journal of Medical and All Body Health Research, vol. 7, no. 3, 2026, pp. 61-65. https://doi.org/10.54660/IJMBHR.2026.7.3.61-65.

Kaushik, P., Srinivas, J., Saxena, R. and Jr, P. (2026) 'Probiotic Use in Gastrointestinal (G.I.T.) Infections', International Journal of Medical and All Body Health Research, 7(3), pp. 61-65. doi: 10.54660/IJMBHR.2026.7.3.61-65.

Kaushik P, Srinivas J, Saxena R, Jr P. Probiotic Use in Gastrointestinal (G.I.T.) Infections. International Journal of Medical and All Body Health Research. 2026;7(3):61-65. doi:10.54660/IJMBHR.2026.7.3.61-65

Share

Find this Article on

Google Scholar Semantic Scholar OpenAlex Scilit Crossref ResearchGate BASE

A newly published article may take a few days to appear on these services.